VBI Vaccines Inc. Sustainability Profile
VBI Vaccines Inc., a pioneering biotechnology company headquartered in the United States, focuses on developing innovative vaccines to address significant global health challenges. Founded in 2010, VBI has made notable strides in the vaccine industry, particularly with its proprietary enveloped virus-like particle (eVLP) platform, which enhances the immune response and offers a unique approach to vaccine development. With operational regions extending across North America and Europe, VBI Vaccines is dedicated to advancing its core products, including vaccines for infectious diseases and immuno-oncology. The company has achieved significant milestones, including promising clinical trial results that position it as a key player in the vaccine market. VBI's commitment to scientific excellence and its unique technological advancements underscore its role in shaping the future of vaccine innovation.
DitchCarbon Score
How does VBI Vaccines Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
VBI Vaccines Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
VBI Vaccines Inc.'s reported carbon emissions
VBI Vaccines Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that VBI Vaccines Inc. may not yet have established a comprehensive framework for addressing its carbon footprint or engaging in climate action initiatives. As the industry increasingly prioritises sustainability, it will be essential for VBI Vaccines Inc. to consider developing and communicating its climate commitments to align with broader environmental goals.
How Carbon Intensive is VBI Vaccines Inc.'s Industry?
How Carbon Intensive is VBI Vaccines Inc.'s Location?
VBI Vaccines Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
VBI Vaccines Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
